The drug “Cernilton” (an analogue of the product is not registered) is available in the form of biconvex, round tablets. Color is light or pale yellow. The tablets have small, darker blotches. Means "Cernilton" has a specific smell. The drug has a plant basis.
Means "Zernilton". Instruction manual
The drug is used for benign prostatic hyperplasia .
The tool has anti-edematous and anti-inflammatory effects, actively contributes to the regulation of metabolic (metabolic) processes.
The drug “Cernilton” (reviews and comments of experts confirm this) has a number of useful properties, due to which the synthesis of inflammatory mediators in the arachidonic acid cycle: leukotrienes and prostaglandins is slowed down.
As a result, there is a decrease in edema and inflammation in the tissue of the prostate.
Cernilton (patient reviews indicate this) helps to reduce the intensity of the pain syndrome.
The drug has a muscle relaxant effect. This helps to relax the smooth muscle elements in the back wall of the urethra, due to which, in turn, urination is improved.
The tool helps to reduce the volume of the prostate, blocks alpha1-adrenergic receptors of smooth muscle components in the urethra, has antiandrogenic activity. The drug "Cernilton" (patient reviews also confirm this) helps to normalize erectile function.
The tool is indicated as part of complex therapy for chronic and acute prostatitis, benign prostatic hyperplasia, including in combination with prostatitis.
The drug "Cernilton" (reviews of doctors are unequivocal in that) is not allowed for the appointment in the presence of hypersensitivity to the components.
The drug is recommended for oral administration before meals (usually half an hour). Tablets are washed down with water in a small amount.
In acute prostatitis, four tablets are usually prescribed three times a day. The duration of therapy is determined by the doctor. As a rule, the duration of admission is three months.
With chronic prostatitis, a tablet is recommended three to four times a day. The duration of therapy can be from three to six months.
With benign prostatic hyperplasia , two tablets are prescribed three times a day. The duration of therapy is usually from six to twelve weeks, however, if necessary, can be increased to six months.
When taking the drug, it should be remembered that with hypersensitivity to the components, nausea, vomiting, allergies can occur.
In clinical practice, no cases of overdose have been recorded. There are also no clinically significant information about the interaction of the drug with other medicines.
The appointment of a remedy for chronic prostatitis of a bacterial nature is allowed only in combination with antibacterial agents. Therapy in this case should be monitored by a specialist.